117 related articles for article (PubMed ID: 34466089)
1. Lysed and disrupted
Lee N; Lee S; Jang SW; Shin HS; Park JH; Park MS; Lee BH
Saudi J Biol Sci; 2021 Sep; 28(9):5115-5118. PubMed ID: 34466089
[No Abstract] [Full Text] [Related]
2. A recombinant Bifidobacterium bifidum BGN4 strain expressing the streptococcal superoxide dismutase gene ameliorates inflammatory bowel disease.
Kang S; Lin Z; Xu Y; Park M; Ji GE; Johnston TV; Ku S; Park MS
Microb Cell Fact; 2022 Jun; 21(1):113. PubMed ID: 35672695
[TBL] [Abstract][Full Text] [Related]
3.
Lee SY; Lee BH; Park JH; Park MS; Ji GE; Sung MK
J Med Food; 2022 Feb; 25(2):146-157. PubMed ID: 35148194
[TBL] [Abstract][Full Text] [Related]
4. Production of biologically active human interleukin-10 by Bifidobacterium bifidum BGN4.
Hong N; Ku S; Yuk K; Johnston TV; Ji GE; Park MS
Microb Cell Fact; 2021 Jan; 20(1):16. PubMed ID: 33468130
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant and Anti-Inflammatory Properties of Recombinant
Lin Z; Ku S; Lim T; Park SY; Park MS; Ji GE; O'Brien K; Hwang KT
Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33805797
[No Abstract] [Full Text] [Related]
6. Safety Evaluations of
Kim MJ; Ku S; Kim SY; Lee HH; Jin H; Kang S; Li R; Johnston TV; Park MS; Ji GE
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29747442
[TBL] [Abstract][Full Text] [Related]
7. Review on Bifidobacterium bifidum BGN4: Functionality and Nutraceutical Applications as a Probiotic Microorganism.
Ku S; Park MS; Ji GE; You HJ
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649150
[TBL] [Abstract][Full Text] [Related]
8. Administration of
Kim H; Kim S; Park SJ; Park G; Shin H; Park MS; Kim J
Front Aging Neurosci; 2021; 13():709091. PubMed ID: 34421576
[TBL] [Abstract][Full Text] [Related]
9. Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI promotes neuronal rejuvenation in aged mice.
Kim H; Shin J; Kim S; Kim S; Cho B; Park SJ; Park G; Shin H; Park MS; Kim J
Biochem Biophys Res Commun; 2022 May; 603():41-48. PubMed ID: 35278878
[TBL] [Abstract][Full Text] [Related]
10. Development of Strain-Specific Primers for Identification of
Youn SY; Ji GE; Han YR; Park MS
J Microbiol Biotechnol; 2017 May; 27(5):909-915. PubMed ID: 28237995
[No Abstract] [Full Text] [Related]
11. Production of Selenomethionine-Enriched Bifidobacterium bifidum BGN4 via Sodium Selenite Biocatalysis.
Jin W; Yoon C; Johnston TV; Ku S; Ji GE
Molecules; 2018 Nov; 23(11):. PubMed ID: 30400218
[TBL] [Abstract][Full Text] [Related]
12.
Bu G; Chen G; Li J; Wu D; Liao J
J Investig Med; 2024 Jan; 72(1):67-79. PubMed ID: 37723650
[TBL] [Abstract][Full Text] [Related]
13. Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4(+) CD45RB(high) T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation.
Kim N; Kunisawa J; Kweon MN; Eog Ji G; Kiyono H
Clin Immunol; 2007 Apr; 123(1):30-9. PubMed ID: 17218154
[TBL] [Abstract][Full Text] [Related]
14. High Expression of β-Glucosidase in Bifidobacterium bifidum BGN4 and Application in Conversion of Isoflavone Glucosides During Fermentation of Soy Milk.
You HJ; Ahn HJ; Kim JY; Wu QQ; Ji GE
J Microbiol Biotechnol; 2015 Apr; 25(4):469-78. PubMed ID: 25348696
[TBL] [Abstract][Full Text] [Related]
15. Cloning and Heterologous Expression of the β-Galactosidase Gene from
Park MJ; Park MS; Ji GE
J Microbiol Biotechnol; 2019 Nov; 29(11):1717-1728. PubMed ID: 31581381
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of Bifidobacterium bifidum ATCC 29521 on colitis and its mechanism.
Din AU; Hassan A; Zhu Y; Zhang K; Wang Y; Li T; Wang Y; Wang G
J Nutr Biochem; 2020 May; 79():108353. PubMed ID: 32145470
[TBL] [Abstract][Full Text] [Related]
17. Novel Bifidobacterium promoters selected through microarray analysis lead to constitutive high-level gene expression.
Wang Y; Kim JY; Park MS; Ji GE
J Microbiol; 2012 Aug; 50(4):638-43. PubMed ID: 22923113
[TBL] [Abstract][Full Text] [Related]
18. Effect of probiotics Lactobacillus and Bifidobacterium on gut-derived lipopolysaccharides and inflammatory cytokines: an in vitro study using a human colonic microbiota model.
Rodes L; Khan A; Paul A; Coussa-Charley M; Marinescu D; Tomaro-Duchesneau C; Shao W; Kahouli I; Prakash S
J Microbiol Biotechnol; 2013 Apr; 23(4):518-26. PubMed ID: 23568206
[TBL] [Abstract][Full Text] [Related]
19. Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis.
Philippe D; Heupel E; Blum-Sperisen S; Riedel CU
Int J Food Microbiol; 2011 Sep; 149(1):45-9. PubMed ID: 21257218
[TBL] [Abstract][Full Text] [Related]
20. Anticancerogenic effect of a novel chiroinositol-containing polysaccharide from Bifidobacterium bifidum BGN4.
You HJ; Oh DK; Ji GE
FEMS Microbiol Lett; 2004 Nov; 240(2):131-6. PubMed ID: 15522499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]